Clinical Trial Update: Effects of GSK598809 on Brain Activation in Abstinent Alcoholics [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the effects of GSK598809 on brain activation in abstinent individuals with alcohol dependence; the study has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Dependence
• Substance Dependence

Drugs mentioned

• GSK598809 (GSK598809)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Substance Dependence, Alcohol Dependence | Phase 1 | Status: WITHDRAWN